In this issue

Issue 49 • March 2022

COVID-19 expanded opportunities in remote healthcare unlike we’ve ever seen before, with point-of-care (POC) diagnostics reaping the most benefit. In this issue, we speak to various executives in the POC landscape on how their technologies allow patients, and especially those with chronic conditions, to get better care and understand their medical conditions more effectively.

In another nod to empowering patients, but also helping medical device companies craft better trials, the US Food and Drug Administration also released guidance on how to effectively integrate patient advisors. We speak to experts on how the guidance will push companies to engage with end users, and potential repercussions if sponsors don’t listen to patients.

Elsewhere, we find out how the growing elder population will continue to drive the global medical device market; how the word tendon was the most mentioned orthopaedic term on Twitter in the last few months of 2021; and how “greener” choices in inhalers have earned increasing pharma and device company support. Finally, continuing a discussion from the past issue, we examine how the new UK medical device regulation spells potential trial concerns for some in vitro diagnostic players.

Read on for all this, as well as the latest medical device industry comment, data and analysis from GlobalData.

Jennifer C. Smith-Parker, Editor

Go to article: Home | Point-of-Care diagnosticsGo to article: In this issueGo to article: ContentsGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: PAMA Manufacturing and SterilizationGo to article: BriefingGo to article: Industry newsGo to article: The medical industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: SartoriusGo to article: PicosunGo to article: CommentGo to article: No shortage of hurdles to overcome for implementation of IVDR in Europe for 2022Go to article: Orthopaedics trends: Tendon most mentioned term on Twitter Q4 2021Go to article: The growing elder population will continue to drive the global medical device maGo to article: Sandvik Company InsightGo to article: Sandvik Go to article: In DepthGo to article: Patient advisors: could they change the face of medtech trials?Go to article: New UK medical device regulation spells potential trial concernsGo to article: Point-of-Care diagnostics: A boon awaits under remote healthcareGo to article: “Greener” choices in inhalers garner increasing pharma, device company supportGo to article: mdi ConsultantsGo to article: In DataGo to article: Artificial intelligence hiring in the medical industry rose in January 2022Go to article: J&J top innovator at tail end of 2021Go to article: January 2022 saw a 33% drop in medical devices’ approval in the USGo to article: EventsGo to article: Next Issue